BRINEURA 150 mg, solution for infusion 2 bottles of 5 ml
Active ingredients: Cerliponase alfa
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution and solution for infusion2 bottles of 5 mlintracérébroventriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRINEURA 150 mg, solution pour perfusion
- Pharmaceutical form
- solution et solution pour perfusion
- Route of administration
- intracérébroventriculaire
- Presentation description
- 2 flacon(s) en verre de 5 ml - 1 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- BIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Nov 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65808346CIP75503371CIP133400955033714Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CERLIPONASE ALFAsolution | 150 mg · un flacon de 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.